Much of the garden is asleep during the colder months, but do houseplants go dormant in winter, too? Well, as with plenty of ...

"If we don't recover pretty dramatically between now and Friday's close, so just two days, we will see sell signals in our intermediate-term metrics," the Fairlead Strategies founder and managing ...

According to Katie Stockton, the magnitude of the rebound will determine how much risk still lies ahead for investors. "If we don't recover pretty dramatically between now and Friday's close, so just ...

With a commanding lead over the global EV battery market, CATL now has a new target as it looks to phase out gas-powered vehicles. CATL announced plans to roll out 1,000 EV battery swap stations ...

approved an application for a Phase I clinical trial of an investigational CD123-specific autologous CAR T-cell therapy by the Institute of Hematology and Blood Transfusion (ÚHKT/Eng: IHBT) in Prague ...

CD4 T helper cells are a type of white blood cell called a lymphocyte that serves an important role in your immune system. These cells help defend the body against infection by directing other "killer ...

Both companies are sharing development costs and potential profits, and Sanofi will lead phase 3 development of duvakitug ... although these therapies are very helpful for some people, they don’t work ...

As a long-time Capcom fan, I could not be happier to see these old franchises finally come back. Okami and Onimusha were some of Capcom’s coolest titles ever released on the PlayStation 2. This ...

According to its recent press release, Capcom “is focusing on re-activating dormant IPs that haven’t had a new title launch recently.” In this case, “recently” is a vague term.